Brind.

The patent expiry of Humira is weighing on sentiment, influenced by geopolitical uncertainty in the Middle East.

2 reports, 1 independent Updated Jun 11

Gone quiet

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The patent expiry of Humira is weighing on sentiment, influenced by geopolitical uncertainty in the Middle East.

Who's involved

What this event is mainly about

AbbVie HUMIRA Middle East

How it developed

Newest first. Tap a step to see who reported it.

Jun 11Patent expiry of Humira impacts sentiment amid geopolitical uncertainty in the Middle East.1 source
- yahoo.com
Jun 11AbbVie is utilizing Humira as a legacy product.1 source
- yahoo.com

Keep exploring

The entities involved

AbbVie
pharmaceutical company
- MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
- AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
HUMIRA
Czech company
- Lost patent protection for Humira in the US on August 20, 2025.Thu 06:13
Middle East
geopolitical region encompassing Egypt and most of Western Asia, including Iran
- A US Air Force base in Fairford, located near the Oxfordshire border, is being utilized due to actions in the Middle East.Mon 17:54
- Authorities are investigating an incident at a base in Fairford, with possible links to Iran and Russia.Mon 17:54

Related events

Coverage

Newest first; wire copies grouped

Jun 11yahoo.com
Jun 11yahoo.com